Between 2013 and 2023, the market size value per capita for Penicillins and Streptomycins in bulk in Japan saw a general upward trend. It grew from $0.9 in 2013 to $1.14 in 2023, marking significant variations throughout the years. Notably, there was a peak at $1.25 in 2021 followed by a stabilization at $1.14 by 2023. Over the last five years, the compound annual growth rate (CAGR) indicates slow growth in the Japanese market for these antibiotics.
Key year-on-year variations include a dip of roughly 8.8% from 2021 to 2022, with normalization thereafter.
- Future trends to watch for: - Rise in healthcare demand and aging population in Japan may drive moderate growth. - Potential disruptions from new regulations or alternative antibiotics could impact market dynamics. - Technological advancements and improvements in local production capabilities could further influence market value changes.
